4 Part IgAN Experience
During this presentation you will learn the clinical presentation, diagnosis, prognosis, and unmet treatment needs of IgAN. Read More
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
IgA Nephropathy
Utilization of the International IgA Nephropathy Prediction Tool
What tools can you use to assess your patient’s risk of progression based on their individual characteristics? Dr Shah explains how to harness the Prediction Tool for a more thorough… Read MoreRole of the Renal Pathologist in IgA Nephropathy
Dr Hassler, a renal pathologist and patient living with IgAN, offers insights into the histopathological features that are crucial for accurate diagnosis and risk stratification in IgA nephropathy, highlighting the… Read MoreUnderstanding the IgA Nephropathy Patient Journey
Listen as Kelly Chen, a nephrology healthcare provider and patient living with IgAN, describes the physical, mental, and emotional toll of this chronic, progressive disease. Read MoreThe Immunomodulating Role of B Cells in IgA Nephropathy: Focus on APRIL
Dr Velez discusses the IgAN pathogenic process and the role of APRIL, a cytokine that binds to B cells and drives IgAN pathogenesis. Read MoreQuality of Life
Explore the impact of IgAN on a patient’s mental and emotional health with Dr Kalra. Learn more about the IgAN patient journey: References: Read MorePatient Presentation
Gain insight from Dr Colbert into how patients with IgAN typically present in the clinic. Learn more about the IgAN patient journey: References: Read MorePrognostic Tools
Learn from Dr Lerma about the MEST-C score and how it is used to assess the risk of IgAN progression. Learn more about the evolving clinical approach to IgAN: References: Read MoreGaps in Treatment
Examine gaps in the current IgAN treatment landscape with Dr Colbert. Learn more about the evolving clinical approach to IgAN: Read MoreTreatment Landscape
Explore the evolving treatment landscape of IgAN with Dr Colbert. Learn more about the evolving clinical approach to IgAN: Read MoreNephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
